ATRITE

This brand name is authorized in Nigeria.

Active ingredients

The drug ATRITE contains one active pharmaceutical ingredient (API):

1	Piroxicam UNII 13T4O6VMAM - PIROXICAM
	Piroxicam is a non-steroidal anti-inflammatory agent with analgesic and antipyretic activity. It is effective regardless of the aetiology of the inflammation.
	Read more about Piroxicam

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
04-2383	Capsule	ATRITE CAPSULES CAP 20 mg 1010's	ATRITE CAPSULES PIROXICAM CAPSULES BP 20MG Each Capsule contains Piroxicam BP 20.00 mg Maize Starch BP 75.00mg Lactose BP 119.50 mg Purified Talc BP 5.0 mg Colloidal Silicon Dioxide (Aerosil-200) 0.5 mg Empty hard gelatin capsules size ‘2’ Scarlet cap/Scarlet body –printed- Atrite on cap and Body IH 1.0 no Apr-83 Drugs MUSCULO-SKELETAL SYSTEM Nigerian Products 1010's POM 1 08/12/2022 SAGAR VITACEUTICALS NIGERIA LTD., PLOT 2, LADIPO OLUWOLE STREET 9022977711 suptpharm@svnl.in Sagar Vitaceuticals Nigeria Limited, Plot 2, Ladipo Oluwole Street, Off Oba Akran Avenue, Ikeja, Lagos, Nigeria, Nigeria	30/11/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
M01AC01	Piroxicam	M Musculo-skeletal system → M01 Antiinflammatory and antirheumatic products → M01A Antiinflammatory and antirheumatic products, non-steroids → M01AC Oxicams
Discover more medicines within M01AC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	04-2383